Amesite Inc. (AMST) Stock Price & Analysis
Amesite Inc. (AMST) rose 3.99% to USD 0.99 as of July 25, 2026 at 08:00 UTC, according to Nexqual real-time market data.
AMST last closed at USD 0.95; the session ranged USD 0.92–0.99 on volume of 104,649 shares. Market capitalization is $5.79M, with a 52-week range of USD 0.77–4.78 (NCM). Source: Nexqual, July 25, 2026 at 08:00 UTC.
Key Statistics (as of July 25, 2026 at 08:00 UTC)
| Price | USD 0.99 |
|---|---|
| Change | ▲ 3.99% (up) |
| Previous Close | USD 0.95 |
| Open | USD 0.93 |
| Day Range | USD 0.92 – 0.99 |
| 52-Week Range | USD 0.77 – 4.78 |
| Volume | 104,649 shares |
| Market Cap | $5.79M |
| Exchange | NCM |
Technical Analysis (AMST)
Nexqual's technical model rates AMST "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 08:00 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.03 (neutral) |
| vs SMA50 | Below (USD 1.25) |
| MACD | -0.07 (negative) |
Analyst Ratings (AMST)
Wall Street analysts rate AMST "None", per Nexqual as of July 25, 2026 at 08:00 UTC.
| Consensus Rating | None |
|---|
Earnings (AMST)
Source: Nexqual, July 25, 2026 at 08:00 UTC.
Financials & Fundamentals (AMST)
| Total Revenue | $341,437 |
|---|---|
| Revenue Growth (YoY) | +171.50% |
| Gross Margin | +100.00% |
| Operating Margin | -820.90% |
| Profit Margin | +0.00% |
| ROE | -121.49% |
| Current Ratio | 4.33 |
| Total Cash | $640,711 |
| Total Debt | $0 |
| Free Cash Flow | $-1.38M |
Source: Nexqual, July 25, 2026 at 08:00 UTC.
Financial Health Score (AMST)
Nexqual rates Amesite Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 08:00 UTC.
| Growth | Strong — Revenue +172% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $641K cash, no debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -121%, ROA -69.5% |
Ownership (AMST)
| Insider Ownership | +32.94% |
|---|---|
| Institutional Ownership | +4.97% |
| Shares Outstanding | 5.85M |
| Float | 2.79M |
| Short % of Float | +1.45% |
Source: Nexqual, July 25, 2026 at 08:00 UTC.
Leadership (AMST)
Amesite Inc. is led by Ann Marie Sastry (age 57), Chairperson, President & CEO, per Nexqual as of July 25, 2026 at 08:00 UTC.
| Chairperson, President & CEO | Ann Marie Sastry (age 57) |
|---|
Major Backers & Investors (AMST)
Notable institutional backers of Amesite Inc. include Focus Partners Wealth, Fidelity, Xtx Topco Ltd, according to Nexqual as of July 25, 2026 at 08:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Focus Partners Wealth | 2.53% |
| Fidelity | 0.73% |
| Xtx Topco Ltd | 0.16% |
| Osaic Holdings Inc. | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.13% |
| Geode Capital | 0.82% |
| State Street | 0.48% |
Source: Nexqual, July 25, 2026 at 08:00 UTC.
From Amesite Inc.'s Latest SEC 10-K Filing (filed 2025-09-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States.
- Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AUUD | Auddia Inc. | USD 1.07 | ▼ 6.14% |
| IFBD | Infobird Co., Ltd | USD 1.07 | ▲ 0.94% |
| PRFX | PRF Technologies Ltd. | USD 1.14 | ▼ 5.42% |
| INM | InMed Pharmaceuticals Inc. | USD 1.71 | ▲ 3.01% |
| DBGI | Digital Brands Group, Inc. | USD 12.9 | ▼ 35.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:00 UTC. This page is informational and not investment advice.